A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLT

Transplant Proc. 1998 Jun;30(4):1445-6. doi: 10.1016/s0041-1345(98)00309-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Azathioprine / therapeutic use
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppression / methods*
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Function Tests
  • Liver Function Tests
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology
  • Male
  • Middle Aged
  • Placebos
  • Prednisolone / therapeutic use
  • Receptors, Interleukin-2 / immunology
  • Survival Rate
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Placebos
  • Receptors, Interleukin-2
  • Cyclosporine
  • Prednisolone
  • inolimomab
  • Azathioprine